Resources

In the Democratic Republic of the Congo (DRC), community care sites (CCS) are small health posts stationed across the country and run by two community health workers. The CCS are used to bring essential health care to hard to reach communities, especially those without an accessible health facility.PATH's Malaria Control and Elimination Partnership in Africa (MACEPA) and Rotary Healthy Communities Challenge (RHCC) teams collaborated to apply geospatial modeling to recommend strategic placement of CCS to the DRC Ministry of Health.Learn more about this process and the work in the brief below.

Africa has made significant strides toward strengthening health security. Diagnostic manufacturing capacity is expanding, and hundreds of products have received regulatory approval. Yet a critical question remains: are Africa’s diagnostic systems ready to deliver when and where they are needed most?The latest report in the Blindspots series from PATH and Impact Global Health reveals a complex picture. Drawing on data on approved diagnostics, global R&D investment trends, manufacturing capacity, and regulatory systems, the report examines how well Africa’s diagnostic ecosystem is aligned with the diseases prioritized by the Africa Centres for Disease Control and Prevention (Africa CDC).The findings reveal a persistent gap between progress and preparedness:577 diagnostics have received regulatory approval, reflecting growing product availability.Diagnostic manufacturing capacity is expanding, creating new opportunities for regional production.R&D investment continues to decline, limiting innovation and the development of future-ready tools.Nearly half of approved diagnostics remain inaccessible at the primary care level, where most people first seek healthcare.This gap highlights a critical blindspot: diagnostic readiness cannot be achieved through political commitments alone. It requires sustained investment, fit-for-purpose regulatory pathways, and financing and procurement systems that enable African manufacturers to produce and deliver the diagnostics communities need.The report identifies priority actions to strengthen Africa’s diagnostic ecosystem, including:reversing declining investment in diagnostic research and development;establishing diagnostics as a distinct regulatory category within the African Medicines Agency framework; andcreating sustainable demand, financing, and market-shaping mechanisms to support African manufacturers.The diagnostics deficit is the second publication in the Blindspots series, jointly produced by Impact Global Health and PATH, examining overlooked barriers that stand between health commitments and real-world impact.

Artificial intelligence has evolved from pilot experimentation to real-world application across health systems worldwide. Over the last five years, AI has taken hold in areas such as clinical documentation, diagnostics, disease surveillance, and clinical decision-making. Yet a common pattern persists across regions: innovation continues to move quickly at the periphery while institutional adoption lags at the center. Many efforts remain siloed, project-based, and dependent on external funding, with little evidence of sustained use or country-led ownership.PATH and the Organisation for Economic Co-operation and Development (OECD) jointly convened AI and Public Health: Expert Dialogues on Strategy, Governance, and Ecosystem Transformation under the PhixAI Initiative, a six-month virtual series held from June 2025 to November 2025. The series aimed to strengthen collective action and leadership around the ethical, equitable deployment of AI within health systems. Across a set of 90-minute sessions, participants explored critical structural themes, including building AI for low-connectivity settings, expanding use cases within public health infrastructure, securing sustainable financing, preparing the health workforce, and shaping regulatory and governance frameworks.Drawing on these conversations, this compendium brings together perspectives from leading experts and organizations advancing durable, system-integrated AI adoption in public health, offering actionable guidance for embedding AI into national health systems in ways that are both sustainable and equitable.

This fact sheet explains how standardized internal process controls strengthen wastewater surveillance by ensuring reliable detection of viral and bacterial pathogens. It highlights PATH and the UK Medicines and Healthcare products Regulatory Agency's (MHRA) development of safe, stable, low‑cost bacterial and viral controls that improve data quality across global wastewater testing systems.

In Uganda, children receive the malaria vaccine at 6 months, 7 months, 8 months, and 18 months of age. But ensuring that children complete the entire four-dose schedule presents challenges, especially for caregivers who live far from the nearest health center, are juggling responsibilities at work and at home, or lack adequate information about where and when to get their children vaccinated.To address these challenges, PATH is partnering with Communication for Development Foundation Uganda (CDFU) on a call center program that provides information to parents and other caregivers about malaria vaccination, reminders about the schedule, and referrals to vaccinating centers to ensure that children stay up to date on all four doses. This case study provides an overview of the program, which is being piloted at 60 health facilities across four districts in Uganda’s South-Central region.